Antipsychotic-Induced Hyponatraemia
| Autor: | Meulendijks, L.A., Mannesse, C.K., Jansen, P.A.F., van Marum, R.J., Egberts, A.C.G., Pharmacoepidemiology, Population-based studies of drug treatment: from molecule to patient outcomes, Dep Farmaceutische wetenschappen |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Pediatrics Epidemiology medicine.medical_treatment Biomedische technologie en medicijnen Toxicology Inappropriate ADH Syndrome Pharmacotherapy Risk Factors medicine Humans Pharmacology (medical) Antipsychotic Adverse effect Psychiatry Ziekenhuisstructuur en organisatie van de gezondheidszorg Pharmacology Dose-Response Relationship Drug business.industry Mental Disorders Incidence (epidemiology) Farmacie(FARM) medicine.disease Schizophrenia Public Health medicine.symptom business Hyponatremia Polydipsia Thirst Adverse drug reaction Antipsychotic Agents |
| Zdroj: | Drug Safety, 33(2), 101. Springer International Publishing Switzerland |
| ISSN: | 0114-5916 |
| DOI: | 10.2165/11319070-000000000-00000 |
| Popis: | Hyponatraemia is known to occur as a rare but clinically important adverse reaction to treatment with different psychotropic drugs, including selective serotonin reuptake inhibitors and antiepileptic drugs. In past decades, reports have been published that describe the development of hyponatraemia in association with antipsychotic drug treatment. Our objective was to systematically review the available evidence on antipsychotic-induced hyponatraemia, focussing on patient characteristics, drug dosage, polydipsia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). A search was carried out in the MEDLINE and EMBASE databases from January 1966 to 11 April 2009. Inclusion criteria were (i) hyponatraemia (serum sodium level |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink